Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of...

Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2009

-- Podcast to be Available Following Conference Call --
CAMBRIDGE, Mass.--(Business Wire)--
Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30
p.m. EDT on Thursday, August 7, 2008 to discuss the company's
financial results for its first quarter of fiscal 2009. Management
will review the quarter and provide an update on the company.

The conference call will be webcast on the investor relations
section of Alkermes' website at www.alkermes.com or may be accessed by
dialing 1-866-793-1306 for domestic callers and 1-703-639-1308 for
international callers. The conference call ID number is 1262420.

A replay of the conference call will be available from 7:30 p.m.
EDT on Thursday, August 7, 2008 through 5 p.m. EDT on Thursday, August
14, 2008, and may be accessed by visiting Alkermes' website or by
dialing 1-888-266-2081 for domestic callers and 1-703-925-2533 for
international callers. The replay access code is 1262420. Alkermes is
also providing a podcast MP3 file available for download on the
Alkermes website, which will be available shortly following the
conference call and will be available until Thursday, August 14, 2008.

About Alkermes

Alkermes, Inc., a biotechnology company committed to developing
innovative medicines to improve patients' lives, manufactures
RISPERDAL(R) CONSTA(R) for schizophrenia and developed and
manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust
pipeline includes extended-release injectable, pulmonary and oral
products for the treatment of prevalent, chronic diseases, such as
central nervous system disorders, addiction and diabetes.
Headquartered in Cambridge, Massachusetts, Alkermes has research and
manufacturing facilities in Massachusetts and Ohio.

Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Associate, Corporate Communications

Copyright Business Wire 2008